Patricia Andrews has been appointed CEO of Boston Biomedical. Andrews will succeed Chiang Li, who has led the company since he founded the Cambridge, MA-based cancer drug developer in 2007. Andrews came to Boston Biomedical in 2013 from Wilmington, DE-based Incyte (NASDAQ: INCY), where she was chief commercial officer. Boston Biomedical promoted her to chief operating officer in 2015. She starts as CEO on April 24.